Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Capital One
COF
|
+$445M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$405M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$387M |
| 4 |
Johnson & Johnson
JNJ
|
+$256M |
| 5 |
Procter & Gamble
PG
|
+$170M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$536M |
| 2 |
NVIDIA
NVDA
|
+$471M |
| 3 |
X
US Steel
X
|
+$421M |
| 4 |
JPMorgan Chase
JPM
|
+$237M |
| 5 |
Deere & Co
DE
|
+$235M |
Sector Composition
| 1 | Technology | 20.97% |
| 2 | Financials | 18.52% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Healthcare | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Ouster
OUST
$1.67B
| $14.1M | ﹤0.01% |
581,343
+9,723
| +2% | +$236K |
|
2127
Southern First Bancshares
SFST
$366M
| $14.1M | ﹤0.01% |
370,067
+9,167
| +3% | +$349K |
|
2128
Ranger Energy Services
RNGR
$298M
| $14.1M | ﹤0.01% |
1,177,363
+69,428
| +6% | +$829K |
|
2129
Civeo
CVEO
$287M
| $14.1M | ﹤0.01% |
608,504
+46,828
| +8% | +$1.08M |
|
2130
TransAlta
TAC
$3.75B
| $14M | ﹤0.01% |
1,300,288
+120,630
| +10% | +$1.3M |
|
2131
Gannett
GCI
$620M
| $14M | ﹤0.01% |
3,915,327
-1,094,235
| -22% | -$3.92M |
|
2132
Bloomin' Brands
BLMN
$577M
| $14M | ﹤0.01% |
1,626,741
-45,487
| -3% | -$392K |
|
2133
Xencor
XNCR
$613M
| $14M | ﹤0.01% |
1,780,570
+43,182
| +2% | +$339K |
|
2134
MiMedx Group
MDXG
$1.03B
| $13.9M | ﹤0.01% |
2,283,249
+274,090
| +14% | +$1.67M |
|
2135
Frontier Group Holdings
ULCC
$1.18B
| $13.9M | ﹤0.01% |
3,835,013
+1,575,446
| +70% | +$5.72M |
|
|
LX
2136
LexinFintech Holdings
LX
$961M
| $13.9M | ﹤0.01% |
1,926,713
+79,093
| +4% | +$571K |
|
|
WBA
2137
DELISTED
Walgreens Boots Alliance
WBA
| $13.9M | ﹤0.01% |
1,208,771
-598,534
| -33% | -$6.87M |
|
2138
First Foundation Inc
FFWM
$493M
| $13.8M | ﹤0.01% |
2,710,776
+364,960
| +16% | +$1.86M |
|
2139
Lands' End
LE
$475M
| $13.8M | ﹤0.01% |
1,289,618
+84,985
| +7% | +$910K |
|
|
AAT
2140
American Assets Trust
AAT
$1.27B
| $13.8M | ﹤0.01% |
698,237
-6,404
| -0.9% | -$126K |
|
2141
Edgewise Therapeutics
EWTX
$1.5B
| $13.8M | ﹤0.01% |
1,048,936
+381,437
| +57% | +$5M |
|
2142
Sarepta Therapeutics
SRPT
$1.82B
| $13.7M | ﹤0.01% |
803,888
+217,570
| +37% | +$3.72M |
|
2143
Banco Santander Chile
BSAC
$12.1B
| $13.7M | ﹤0.01% |
541,864
+34,723
| +7% | +$875K |
|
2144
ATN International
ATNI
$238M
| $13.6M | ﹤0.01% |
836,899
-3,291
| -0.4% | -$53.5K |
|
2145
Western New England Bancorp
WNEB
$250M
| $13.6M | ﹤0.01% |
1,471,288
-6,999
| -0.5% | -$64.6K |
|
2146
Coca-Cola Femsa
KOF
$18B
| $13.6M | ﹤0.01% |
140,456
-1,375
| -1% | -$133K |
|
2147
RBB Bancorp
RBB
$332M
| $13.5M | ﹤0.01% |
786,011
+26,554
| +3% | +$457K |
|
2148
Peoples Financial Services
PFIS
$525M
| $13.5M | ﹤0.01% |
273,917
+18,942
| +7% | +$935K |
|
2149
Yext
YEXT
$1.07B
| $13.5M | ﹤0.01% |
1,590,491
-76,857
| -5% | -$653K |
|
2150
Arcus Biosciences
RCUS
$1.23B
| $13.5M | ﹤0.01% |
1,659,879
-62,204
| -4% | -$506K |
|